Ticker APHA – Aphria – sales, description, marketcap – Tickerday.com

APHA

Aphria

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 1.16B; Volume: 2.93M; AvgVol 3m: 5.19M; Beta: –;

Cost estimate:

P/E: –; EPS: –; EPS growth quarter/prev quarter: ;

EPS growth this year: ; EPS growth past 5 years: ;

EPS ttm: 0.30;

P/S: ; P/B: 0.92; P/Cashflow: ; P/FCF: ;

Sales: –; Sales growth quarter/prev quarter: 18.40%; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 2.84%; Insider Transactions:0.00%;

Institutional Ownership: 14.42%; Institutional Transactions: ;

Data update: 07/10/2020.